Dong-Ho Choi
Hanyang University · 医学
研究室紹介
Professor Dong-Ho Choi's research lab specializes in regenerative medicine and bioengineering, with a focus on stem cell biology, hepatocyte differentiation, and the development of bioartificial tissues for liver disease treatment. The lab investigates the differentiation of embryonic and induced pluripotent stem cells into functional hepatocytes, explores 3D bioprinting technologies using hepatocyte-like cells, and develops patient-specific hepatic cell sheets for transplantation. A key aim is to create scalable, renewable cell sources and advanced biomaterial scaffolds to enable clinical applications in liver regeneration.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15CD markers were related to invasiveness and differentiation of colorectal adenocarcinoma. However, CD expression was not closely related to survival.
Embryonic stem (ES) cells have been regarded as a powerful resource for cell replacement therapy. In recent reports mouse ES cells have been successfully applied in the treatment of spinal cord injury, hereditary myelin disorder of the central nervous system, and diabetes mellitus. Another type of disease that could benefit from the availability of stem cell therapy is liver disease. However, for this potential to be realized, it is necessary to demonstrate the differentiation of ES cells into h
Embryonic stem (ES) cells have the potential to differentiate into all three germ layers, providing new perspectives not only for embryonic development but also for the application in cell replacement therapies. Even though the formation of an embryoid body (EB) in a suspension culture has been the most popular method to differentiate ES cells into a wide range of cells, not much is known about the characteristics of EB cells. To this end, we investigated the process of EB formation in the suspe
Three-dimensional (3D) bioprinting technology is a promising new technology in the field of bioartificial organ generation with regard to overcoming the limitations of organ supply. The cell source for bioprinting is very important. Here, we generated 3D hepatic scaffold with mouse-induced hepatocyte-like cells (miHeps), and investigated whether their function was improved after transplantation in vivo. To generate miHeps, mouse embryonic fibroblasts (MEFs) were transformed with pMX retroviruses